Long-term low dose azithromycin treatment in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection is safe and reduces the decline in lung function, the number of acute exacerbations and improves nutritional status; underlying efficacy mechanisms are multiple and synergistic.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
pseudomonas aeruginosa
8
[macrolides pseudomonas
4
aeruginosa cystic
4
cystic fibrosis]
4
fibrosis] long-term
4
long-term low
4
low dose
4
dose azithromycin
4
azithromycin treatment
4
treatment cystic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!